272 related articles for article (PubMed ID: 12853697)
1. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
2. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels.
Ando M; Iwamoto Y; Suda A; Tsuchiya K; Nihei H
Blood; 2001 Feb; 97(4):915-21. PubMed ID: 11159517
[TBL] [Abstract][Full Text] [Related]
3. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
4. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
5. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
Nikolaev AIu; Klepikov PV; Lashutin SV
Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
[No Abstract] [Full Text] [Related]
6. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
7. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
[TBL] [Abstract][Full Text] [Related]
8. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
Marsden JT; Sherwood RA; Hillis A; Peters TJ
Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
[No Abstract] [Full Text] [Related]
9. Should the hematocrit be normalized in dialysis and in pre-ESRD patients?
Macdougall IC
Blood Purif; 2001; 19(2):157-67. PubMed ID: 11150803
[No Abstract] [Full Text] [Related]
10. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
11. Effects of withdrawing erythropoietin.
Taylor JE; Henderson IS; Mactier RA; Stewart WK
BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
[No Abstract] [Full Text] [Related]
12. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
14. Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.
Garcia-Canton C; Palomar R; Moreno A; Toledo A; Suria S; Esparza N; Rossique P; Checa MD
Nephron; 1996; 74(2):444-5. PubMed ID: 8893180
[No Abstract] [Full Text] [Related]
15. Target haematocrit during erythropoietin treatment in dialysis patients. Which value is 'true-functional haematocrit'?
Vlassopoulos D; Sonikian M; Dardioti V; Hadjiconstantinou V
Nephrol Dial Transplant; 1999 May; 14(5):1340-1. PubMed ID: 10344405
[No Abstract] [Full Text] [Related]
16. [Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis].
Sułowicz W; Hanicki Z; Skotnicki AB; Wójcik J; Sydor A
Przegl Lek; 1992; 49(3):88-90. PubMed ID: 1438902
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of renal anemia with recombinant human erythropoietin].
Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
[TBL] [Abstract][Full Text] [Related]
18. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: a multicentre cross-sectional study.
Valga F; Monzón T; Henriquez F; Santana-Del-Pino A; Antón-Pérez G
Nefrologia (Engl Ed); 2020; 40(3):320-327. PubMed ID: 31839207
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
Zehnder C
Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
[No Abstract] [Full Text] [Related]
20. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
